From Shweta Rai, Director of Bayer Zydus Pharma Private Limited and Country Division Head for Bayer’s Pharmaceuticals Business in South Asia- 

“The interim Budget 2024 has some notable announcements highlight the Government’s aim to prioritize women’s health in the country, which is commendable. We welcome the move to improve the rate of HPV vaccination in the country and integrate schemes for maternal health and childcare under one umbrella will help to streamline the implementation of both schemes and improve the impact on women’s and children’s health. We look forward to more announcements and opportunities in the upcoming Union Budget that would prioritize women’s health along with research and innovation to improve the pharma landscape in the country.“

From Mr. Sandeep Verma, Country Head, Bayer Consumer Health Division, India –  

“It is encouraging to see that the interim budget has taken into account nutrition delivery to the last mile. It sets the stage for creating a strong healthcare model for the country, and signals that we are thinking ahead. The increased allocations for PMABHIM, Ayushman Bharat-PMJAY and the continued thrust on digitization reflects the Government’s strong commitment to improving India’s public health infrastructure. We look forward to more allocations in the upcoming Union Budget 2024 to promote responsible self-care practices and further strengthen the primary care infrastructure in India that increases access to healthcare for all. “